Associated Papers
Hepatocellular adenoma classification: a comparative evaluation of immunohistochemistry and targeted mutational analysis.
Margolskee E et al.
Diagnostic Pathology, 2016
Biochemical and functional analyses of gp130 mutants unveil JAK1 as a novel therapeutic target in human inflammatory hepatocellular adenoma.
Poussin K et al.
Oncoimmunology, 2013
24501689 (PubMed )
Supplement: onci-2-e27090-s01.pdf
High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions.
Nault JC et al.
Nature Communications, 2013
23887712 (PubMed )
Supplement: ncomms3218-s1.pdf
Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours.
Rebouissou S et al.
Nature, 2009
Select a paper to view details